• Dacomitinib (PF-00299804): Mechanism and Applications in Can

  2026-07-03

  Dacomitinib (PF-00299804) is a potent irreversible pan-HER inhibitor, exhibiting strong efficacy against EGFR, HER2, and HER4-driven cancer models. It induces apoptosis and cell cycle G0–G1 arrest in resistant cancer cell lines. The compound's well-characterized mechanism supports its use in translational oncology workflows.

• Nur77 Phase Separation Drives Apoptosis via Nur77/Bcl-2 Cond

  2026-07-03

  The referenced study identifies XS561 as a novel ligand that triggers apoptosis in tumor cells by promoting phase separation of Nur77 and the formation of Nur77/Bcl-2 mitochondrial condensates. This work reveals a mechanistic link between liquid–liquid phase separation and the activation of the caspase signaling pathway, underscoring new therapeutic avenues in drug-resistant breast cancers.

• ML385: Advanced NRF2 Inhibitor Applications Beyond Oncology

  2026-07-02

  Discover how ML385, a selective NRF2 inhibitor, empowers research not only in cancer therapeutic resistance but also in oxidative stress and neuronal ferroptosis. This article delivers in-depth scientific insights and practical protocol guidance distinct from standard cancer-focused reviews.

• EphA2 as a Synthetic Lethal Target in MYC-Driven TNBC

  2026-07-02

  This study establishes EphA2 as a synthetic lethal vulnerability in MYC-driven triple-negative breast cancer (TNBC) using chemogenetic screening. The findings provide a new strategy for targeting aggressive MYC-activated cancers, independent of p53 status, and highlight the translational potential of pathway-specific targeting in oncology.

• Pravastatin Sodium: Mechanistic Precision for Translational

  2026-07-01

  This thought-leadership article bridges the molecular mechanisms of Pravastatin sodium—a highly selective HMG-CoA reductase inhibitor—with strategic translational guidance. By examining cholesterol biosynthesis inhibition, LDL cholesterol reduction, and transporter interplay, it empowers researchers to design robust experiments and anticipate clinical translation hurdles. Drawing on recent hepatocyte studies, critical protocol parameters, and APExBIO’s product intelligence, this piece uniquely positions Pravastatin sodium within the evolving landscape of cardiovascular and metabolic research.

• Saracatinib (AZD0530): Reliable Src/Abl Inhibition for Cell

  2026-07-01

  This article provides practical, scenario-based guidance for using Saracatinib (AZD0530), SKU A2133, in cell viability, proliferation, and migration assays. Bench scientists will find evidence-backed answers to common experimental challenges, workflow optimization tips, and candid vendor comparisons—anchored by APExBIO’s validated supply of Saracatinib (AZD0530).

• FLAG tag Peptide (DYKDDDDK): Precision Tag for Protein Purif

  2026-06-30

  Unlock next-generation recombinant protein workflows with the FLAG tag Peptide (DYKDDDDK) from APExBIO. This guide delivers actionable protocols, advanced troubleshooting, and the latest reference-driven innovations for streamlined detection and purification in complex research settings.

• Reelin-SFK Signaling Is Essential for Ketamine’s Antidepress

  2026-06-30

  This study establishes that intact synaptic Reelin signaling via Apoer2 and Src family kinases (SFKs) is a prerequisite for the synaptic plasticity and behavioral effects of ketamine in mouse models. Disruption of any component in this pathway abrogates ketamine’s efficacy, offering mechanistic insight into nonresponsiveness in treatment-resistant depression and opening new routes for translational research.

• VX-661: Precision F508del CFTR Corrector for Cystic Fibrosis

  2026-06-29

  VX-661 (F508del CFTR corrector) empowers researchers to restore chloride channel function in cystic fibrosis models with robust, reproducible workflows. This guide translates the latest calnexin-dependent findings into actionable protocols and troubleshooting strategies for advanced CFTR modulation studies.

• Recombinant Human FGF-19: Precision Tools for Metabolic and

  2026-06-29

  Explore the advanced scientific applications of Recombinant Human FGF-19 in metabolic and inflammatory research. This in-depth article highlights unique mechanistic insights and practical assay guidance to elevate your FGF-19 protein studies.

• Patient-Derived Gastric Cancer Assembloids: Modeling Tumor-S

  2026-06-28

  A recent study introduces a patient-specific gastric cancer assembloid model that integrates matched tumor organoids and stromal cell subpopulations, closely mimicking the tumor microenvironment. This innovation enables a more accurate investigation of drug responses, resistance mechanisms, and cellular heterogeneity, with direct implications for personalized cancer therapy development.

• Smg5-Driven NMD Regulates Oligodendrocyte Differentiation vi

  2026-06-27

  This study demonstrates that Smg5-mediated nonsense-mediated mRNA decay (NMD) is essential for oligodendrocyte maturation, acting through the selective degradation of aberrant Hnrnpl transcripts. The findings reveal a critical Smg5–Hnrnpl–Mag regulatory axis necessary for proper myelination in the central nervous system, with implications for posttranscriptional gene regulation in neural development.

• Gentamycin Sulfate in Resistance Research: Protocols & Insig

  2026-06-26

  Gentamycin Sulfate empowers advanced studies of Gram-negative resistance, ribosome function, and protein synthesis disruption. This guide details experimental protocols, troubleshooting, and key innovations, bridging applied workflows with the latest research findings.

• Reactive Oxygen Species Assay Kit: Unveiling ROS Dynamics in

  2026-06-26

  Explore the scientific underpinnings and advanced applications of the Reactive Oxygen Species Assay Kit for precise oxidative stress measurement. This article provides unique insight into ROS detection's role in cancer immunotherapy and practical assay optimization.

• Ziprasidone HCl in Translational Oncology: Protocols & Insig

  2026-06-25

  Ziprasidone Hydrochloride (Ziprasidone HCl) extends beyond its psychiatric origins to offer unique antitumor and neuropharmacological assay potential. This article demystifies experimental workflows, highlights validated protocol parameters, and offers troubleshooting tips—all grounded in the latest mechanistic and clinical evidence.

444 records 12/30 page Previous Next First page 上5页 1112131415 下5页 Last page